DRI
56
2
AA
38
-2
AES
41
2
FOX
57
-3
TXT
62
2
DLTR
40
4
VNO
60
8
DG
12
2
WDC
38
-3
PG
50
2
MS
80
-3
SLG
62
-4
GOOGL
59
-8
KEY
46
-2
CSX
68
3
DE
36
-2
OMC
64
-2
CAH
60
2
SHW
70
2
BA
45
-3
DRI
56
2
AA
38
-2
AES
41
2
FOX
57
-3
TXT
62
2
DLTR
40
4
VNO
60
8
DG
12
2
WDC
38
-3
PG
50
2
MS
80
-3
SLG
62
-4
GOOGL
59
-8
KEY
46
-2
CSX
68
3
DE
36
-2
OMC
64
-2
CAH
60
2
SHW
70
2
BA
45
-3
Financhill
Back

Prelude Therapeutics Vs. IGC Pharma Industry Stock Comparison

Sell
19

PRLD
Prelude Therapeutics

Last Price:
1.03
Seasonality Move:
21.44%
Sell
32

IGC
IGC Pharma

Last Price:
0.35
Seasonality Move:
-8.68%
Sell
19
Prelude Therapeutics (PRLD) is a Sell

Is Prelude Therapeutics a Buy, Sell or Hold?

  • The current Prelude Therapeutics [PRLD] share price is $1.06. The Score for PRLD is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • PRLD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
32
IGC Pharma (IGC) is a Sell

Is IGC Pharma a Buy, Sell or Hold?

  • The current IGC Pharma [IGC] share price is $0.37. The Score for IGC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRLD Stock Price Chart

What is Prelude Therapeutics's stock price today?

  • The Prelude Therapeutics share price today is $1.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.

IGC Stock Price Chart

What is IGC Pharma's stock price today?

  • The IGC Pharma share price today is $0.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing slight buying pressure.

PRLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 21.5 Sell
Chaikin Money Flow: -457523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 1.83) Sell
Bollinger Bands (100): (1.92 - 5.38) Sell

IGC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 42 Sell
Chaikin Money Flow: -78366 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.38 - 0.4) Sell
Bollinger Bands (100): (0.36 - 0.44) Sell

PRLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.21 Sell
20-day SMA: 1.42 Sell
50-day SMA: 2.27 Sell
200-day SMA: 3.86 Sell
8-day EMA: 1.21 Sell
20-day EMA: 1.44 Sell
50-day EMA: 2.23 Sell
200-day EMA: 3.56 Sell

IGC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.38 Sell
20-day SMA: 0.39 Sell
50-day SMA: 0.37 Sell
200-day SMA: 0.41 Sell
8-day EMA: 0.38 Sell
20-day EMA: 0.38 Sell
50-day EMA: 0.38 Sell
200-day EMA: 0.4 Sell

Prelude Therapeutics Earnings Growth & PRLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.31 per share.

IGC Pharma Earnings Growth & IGC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.

Prelude Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

IGC Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):